Lumbar WBCT vs MRI

November 10, 2026 updated by: Neil Segal, MD, MS, University of Kansas Medical Center

Standing Weight-Bearing Cone-Beam CT and Clinical Phenotype Concordance in Lumbar Degenerative Radiculopathy

Patients with pain in their low back that sometimes sends a shooting, sharp pain down their leg are usually diagnosed with lumbar radicular pain, or lumbar radiculopathy. MRIs are most commonly used to acquire images of the spine. The purpose of these images is to provide doctors with important information on what may be causing the low back pain and what treatment options may be the most effective in treating the pain. However, standard MRIs are taken when the patient is lying down, which may not be the most accurate representation of what the spine looks like in positions where patients experience pain, such as standing. A weight-bearing CT (WBCT) scan is a 3D imaging test that takes detailed pictures of the spine while patients are standing up. Unlike traditional MRI scans, where the patient lies down, this technology provides more information on how the spine looks when the patient is upright and participating in activities such as standing and walking. This information allows doctors to better understand the underlying causes of the pain and help guide targeted treatments to address those issues.

The Planmed XFI full-body weight-bearing CT scanner received 510(k) clearance from the FDA on September 26, 2025. This means the Planmed XFI® WBCT is safe and effective because it is substantially equivalent to a device already on the market.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Lumbar radicular pain and radiculopathy arise from heterogeneous mechanical and inflammatory processes affecting the lumbar nerve roots. Accurate localization of the symptomatic root determines the target of interventional and surgical treatment, and incorrect localization is a plausible contributor to procedural non-response. MRI is the principal imaging examination for suspected radiculopathy because it depicts the discs, nerve roots, and perineural fat. Its agreement with the clinically symptomatic root, however, is moderate at best. For the present study, a prospectively standardized, blinded, pre-imaging clinical phenotype serves as the operational reference standard. It is performed in every participant before any study imaging, locked before acquisition, and not revised afterward, so that imaging is scored against a fixed clinical target rather than reconciled with it. Across loaded and upright studies, mean positional effects on foraminal dimension are small and directionally mixed, and the literature is heterogeneous in device, posture, loading method, and outcome measure. Standing weight-bearing cone-beam CT provides three-dimensional isotropic imaging of the osseous foraminal boundary under physiological load, permitting quantitative cross-sectional area measurement in neutral and extension within a single session. Soft-tissue contrast is limited relative to MRI, which is why all primary measurements in this protocol are bony-boundary geometric measures. To our knowledge, no previous study has evaluated standing lumbar weight-bearing CT against a prospectively standardized, blinded, pre-imaging clinical phenotype. This study estimates that concordance, estimates whether it differs between neutral and standing extension, and characterizes the magnitude of positional change in foraminal dimension.

Study Type

Observational

Enrollment (Estimated)

90

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Kansas
      • Kansas City, Kansas, United States, 66160
        • University of Kansas Medical Center
        • Contact:
        • Principal Investigator:
          • Neil Segal, MD,MS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adults with lumbar radicular symptoms (unilateral or bilateral with clear unilateral dominance) identified from PM&R spine clinic and affiliated clinics at KUMC.

Description

Inclusion Criteria:

  • Age ≥45 years.
  • Predominant unilateral lumbar radicular pain and/or paresthesias. True bilateral radicular presentations are excluded.
  • Lumbar radicular pattern on chart-review screening - a coarse eligibility filter only. Root level is not assigned at screening; it is assigned by the blinded standardized examination after enrollment (§8).
  • Ability to stand unsupported to undergo study examination and WBCT.
  • Informed consent, including broad re-contact consent and consent to outcomes follow-up.

Exclusion Criteria:

A candidate meeting any of the following is excluded:

  1. True bilateral or symmetric radicular presentation with no dominant symptomatic side. The side-contrast endpoint (§10.3) requires an asymptomatic homolog. Unilaterally dominant presentations with minor contralateral involvement are eligible; isolated laterality is recorded and drives a clean-unilateral sensitivity analysis.
  2. Radicular symptoms attributable to a non-degenerative cause - neoplasm, infection, inflammatory or autoimmune disease, acute fracture, or other non-degenerative structural lesion at the symptomatic level.
  3. Any prior lumbar spine surgery - instrumented fusion, posterior instrumentation, decompression, or discectomy. Altered biomechanics, junctional change, and retained/residual disc or epidural fibrosis distort foraminal and segmental anatomy and confound both measurement and symptom attribution.
  4. Any lumbar spine procedure in the last 12 weeks - including any epidural steroid injection, radiofrequency nerve ablation, facet injection, medial branch block or SI joint injection
  5. Inability to stand and hold the neutral and extension positions for acquisition with no more than light bilateral fingertip contact - from a balance disorder, orthostatic intolerance, lower-limb weakness, weight-bearing restriction, or pain that precludes positioning.
  6. Pregnancy or possibility of pregnancy. Screening and testing per institutional and RSO policy (§13).
  7. BMI > 35 kg/m2. Cone-beam image quality degrades with soft-tissue path length independently of dose, and osseous depiction becomes diagnostically unusable in the 32-35 range (Benz 2018). Because the primary endpoint is a bony-boundary geometric measurement, quality loss translates directly into measurement error. Set pre-emptively rather than by post-acquisition exclusion, which would irradiate participants whose acquisitions are predictably unusable.
  8. Inability to provide informed consent, or insufficient capacity to understand and communicate symptoms for the standardized phenotype examination (§8).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: OTHER
  • Time Perspectives: CROSS_SECTIONAL

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Lumbar WBCT

Participants will be identified through chart-review screening. Eligible and enrolled participants will undergo a blinded, standardized clinical phenotype exam performed by an evaluator blinded to the chart-review call. The participant also will be asked to complete 4 participant-reported surveys (Oswestry Disability Index (ODI), pain numeric rating scale (NRS), patient-reported provocative posture, symptom duration). The participant then will undergo two WBCT scans, one in a neutral position and one in an extension position. These two scans will be performed in the same session.

Participants will undergo two WBCT scans, one in a neutral position and one in an extension position.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of neutral WBCT position to prespecified clinical phenotype
Time Frame: From enrollment to end of visit at 1 day

Estimate the proportion of participants in whom neutral standing WBCT demonstrates prespecified foraminal pathology at the side and root level assigned by the blinded, locked clinical phenotype

From enrollment to end of visit at 1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of extension WBCT position to prespecified clinical phenotype
Time Frame: From enrollment to end of visit at 1 day

Extension secondary. Estimate the proportion of participants in whom spinal extension standing WBCT demonstrates prespecified foraminal pathology at the side and root level assigned by the blinded, locked clinical phenotype; to estimate the within-participant change in concordance between the neutral and extension acquisitions; and to estimate the within-participant side-contrast on each acquisition and its change between them.

From enrollment to end of visit at 1 day
Comparison of standing WBCT to supine MRI images
Time Frame: From enrollment to end of visit at 1 day

MRI secondary. In the MRI-available subset, compare standing WBCT and supine MRI concordance against the same clinical reference standard (paired; McNemar on discordant pairs).

From enrollment to end of visit at 1 day
Comparison of electrodiagnostic (EDX) testing in WBCT vs MRI
Time Frame: From enrollment to end of visit at 1 day

EDX secondary. In the EDX-available and EDX-positive subset, describe WBCT-EDX and MRI-EDX same-level same-side agreement.

From enrollment to end of visit at 1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Neil Segal, MD,MS, University of Kansas Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 1, 2026

Primary Completion (Estimated)

November 1, 2027

Study Completion (Estimated)

November 1, 2027

Study Registration Dates

First Submitted

November 10, 2026

First Submitted That Met QC Criteria

November 10, 2026

First Posted (Actual)

November 17, 2026

Study Record Updates

Last Update Posted (Actual)

November 17, 2026

Last Update Submitted That Met QC Criteria

November 10, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00163008

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

If deidentified IPD is requested, for example for a meta-analysis or other study requiring those data, the investigators would provide those data.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.